BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20949003)

  • 1. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.
    Larkin EA; Stiles BG; Ulrich RG
    PLoS One; 2010 Oct; 5(10):e13253. PubMed ID: 20949003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding site.
    Xia T; Liang S; Wang H; Hu S; Sun Y; Yu X; Han J; Li J; Guo S; Dai J; Lou Z; Guo Y
    MAbs; 2014; 6(1):119-29. PubMed ID: 24423621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.
    Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H
    Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic human monoclonal antibodies toward staphylococcal enterotoxin B (SEB) protective against toxic shock syndrome.
    Karauzum H; Chen G; Abaandou L; Mahmoudieh M; Boroun AR; Shulenin S; Devi VS; Stavale E; Warfield KL; Zeitlin L; Roy CJ; Sidhu SS; Aman MJ
    J Biol Chem; 2012 Jul; 287(30):25203-15. PubMed ID: 22645125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus.
    Aguilar JL; Varshney AK; Pechuan X; Dutta K; Nosanchuk JD; Fries BC
    Virulence; 2017 Aug; 8(6):741-750. PubMed ID: 27715466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
    Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
    Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms mediating enhanced neutralization efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies.
    Dutta K; Varshney AK; Franklin MC; Goger M; Wang X; Fries BC
    J Biol Chem; 2015 Mar; 290(11):6715-30. PubMed ID: 25572397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of staphylococcal enterotoxin B-induced lymphocyte proliferation and tumor necrosis factor alpha secretion by MAb5, an anti-toxic shock syndrome toxin 1 monoclonal antibody.
    Pang LT; Kum WW; Chow AW
    Infect Immun; 2000 Jun; 68(6):3261-8. PubMed ID: 10816471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus.
    Karau MJ; Tilahun ME; Krogman A; Osborne BA; Goldsby RA; David CS; Mandrekar JN; Patel R; Rajagopalan G
    Virulence; 2017 Oct; 8(7):1148-1159. PubMed ID: 27925510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B.
    Hamad AR; Herman A; Marrack P; Kappler JW
    J Exp Med; 1994 Aug; 180(2):615-21. PubMed ID: 7519243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodies.
    Tilahun ME; Rajagopalan G; Shah-Mahoney N; Lawlor RG; Tilahun AY; Xie C; Natarajan K; Margulies DH; Ratner DI; Osborne BA; Goldsby RA
    Infect Immun; 2010 Jun; 78(6):2801-11. PubMed ID: 20308304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel protective human monoclonal antibody, LXY8, that targets the key neutralizing epitopes of staphylococcal enterotoxin B.
    Hu N; Qiao C; Wang J; Wang Z; Li X; Zhou L; Wu J; Zhang D; Feng J; Shen B; Zhang J; Luo L
    Biochem Biophys Res Commun; 2021 Apr; 549():120-127. PubMed ID: 33667709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.
    Tilahun ME; Kwan A; Natarajan K; Quinn M; Tilahun AY; Xie C; Margulies DH; Osborne BA; Goldsby RA; Rajagopalan G
    PLoS One; 2011; 6(11):e27203. PubMed ID: 22102880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine monoclonal antibodies against staphylococcal enterotoxin B: production and characterization.
    Goyache J; Orden JA; Blanco JL; Hernández J; Doménech A; Suárez G; Gómez-Lucía E
    FEMS Microbiol Immunol; 1992 Jul; 4(5):247-54. PubMed ID: 1515153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Detection of Staphylococcal Enterotoxin-B by Lateral Flow Assay.
    Hnasko R; Lin AV; McGarvey JA
    Monoclon Antib Immunodiagn Immunother; 2019 Oct; 38(5):209-212. PubMed ID: 31603743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcal Enterotoxin B-specific monoclonal antibody 20B1 successfully treats diverse Staphylococcus aureus infections.
    Varshney AK; Wang X; Scharff MD; MacIntyre J; Zollner RS; Kovalenko OV; Martinez LR; Byrne FR; Fries BC
    J Infect Dis; 2013 Dec; 208(12):2058-66. PubMed ID: 23922375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of anti-peptide monoclonal antibodies with specificity for staphylococcal enterotoxins A and B.
    Bhatti AR; Micusan VV
    J Microbiol Methods; 1999 Mar; 35(2):143-9. PubMed ID: 10192046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibodies against staphylococcal enterotoxin B-induced lethal shock.
    Varshney AK; Wang X; Cook E; Dutta K; Scharff MD; Goger MJ; Fries BC
    J Biol Chem; 2011 Mar; 286(11):9737-47. PubMed ID: 21233204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of staphylococcal enterotoxin-driven lymphocyte proliferation by anti-MHC class II monoclonal antibody.
    Loh MT; Srinivasan N; Chan SH; Ren EC
    Hybridoma; 1995 Oct; 14(5):429-33. PubMed ID: 8575791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice.
    Varshney AK; Wang X; Aguilar JL; Scharff MD; Fries BC
    mBio; 2014 Jun; 5(3):e01007-14. PubMed ID: 24917594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.